Pierre Thomas, MD, PhD, is affiliated with Lille Neurosciences and Cognition at Lille University Hospital, University of Lille, and the National Institute of Health and Medical Research in Lille, France, as well as the Fédération Régionale de Recherche en Santé Mentale Hauts-de-France. His publications focus on clinical aspects of bipolar disorder, major depressive disorder, schizophrenia and schizoaffective disorders, and suicide risk. Notable topics include metabolic side effects of risperidone in youth with early-onset schizophrenia and characteristics of mixed features in major depressive episodes related to suicide attempts. He has collaborated frequently with Alain Duhmael, Ali Amad, Baptiste Pignon, Emilie Olié, and Géraldine Kechid.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
